R E Coleman
Overview
Explore the profile of R E Coleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
591
Citations
10630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hadji P, Coleman R, Wilson C, Powles T, Clezardin P, Aapro M, et al.
Ann Oncol
. 2015 Dec;
27(3):379-90.
PMID: 26681681
Bisphosphonates have been studied in randomised trials in early breast cancer to investigate their ability to prevent cancer treatment-induced bone loss (CTIBL) and reduce the risk of disease recurrence and...
12.
Taylor F, Short D, Winter M, Tidy J, Savage P, Sarwar N, et al.
Gynecol Oncol
. 2014 Dec;
136(2):258-63.
PMID: 25542400
Objective: To determine whether single agent chemotherapy with intramuscular methotrexate 50mg administered on days 1, 3, 5, and 7 and oral folinic acid 15mg administered on days 2, 4, 6,...
13.
Smith M, Coleman R, Klotz L, Pittman K, Milecki P, Ng S, et al.
Ann Oncol
. 2014 Nov;
26(2):368-74.
PMID: 25425475
Background: In a phase III trial in patients with castration-resistant prostate cancer (CRPC) and bone metastases, denosumab was superior to zoledronic acid in reducing skeletal-related events (SREs; radiation to bone,...
14.
Coleman R, Gregory W, Marshall H, Wilson C, Holen I
Breast
. 2013 Oct;
22 Suppl 2:S50-6.
PMID: 24074793
Metastasis to bone, and indeed potentially to other sites, results from the numerous interactions between cancer cells, haematopoietic stem cells and normal bone cells within the bone marrow microenvironment. These...
15.
Taylor F, Grew T, Everard J, Ellis L, Winter M, Tidy J, et al.
Eur J Cancer
. 2013 Jul;
49(15):3184-90.
PMID: 23870384
Background: Gestational trophoblastic neoplasia (GTN) persisting despite local treatment requires chemotherapy. In 2000, the revised International Federation of Gynaecology and Obstetrics (FIGO)/World Health Organisation (WHO) staging system was introduced, classifying...
16.
Kraus V, Worrell T, Renner J, Coleman R, Pieper C
Osteoarthritis Cartilage
. 2013 Jul;
21(11):1693-9.
PMID: 23867580
Objective: To evaluate ankle joint abnormalities in a knee osteoarthritis (OA) cohort. Methods: Participants (n = 159) with symptomatic and radiographic OA in at least one knee underwent technetium-99m methylene...
17.
Aapro M, van de Velde C, Markopoulos C, Bartlett J, Putter H, Coleman R
Breast
. 2013 Mar;
22(4):488-94.
PMID: 23454040
Background: In the past few years aromatase inhibitors (AIs) have shown superior efficacy to the previous standard adjuvant endocrine therapy, tamoxifen, and are now recommended as part of current adjuvant...
18.
Winter M, Coleman R
Clin Oncol (R Coll Radiol)
. 2012 Dec;
25(2):135-45.
PMID: 23207072
Bisphosphonates, as potent inhibitors of osteoclast-mediated bone resorption, significantly reduce the risk of skeletal complications in metastatic bone disease and also prevent cancer treatment-induced bone loss (CTIBL). However, more recently,...
19.
Scott E, Daley A, Doll H, Woodroofe N, Coleman R, Mutrie N, et al.
Cancer Causes Control
. 2012 Nov;
24(1):181-91.
PMID: 23184120
Excess body weight at diagnosis and weight gain after breast cancer are associated with poorer long-term prognosis. This study investigated the effects of a lifestyle intervention on body weight and...
20.
Hadji P, Gnant M, Body J, Bundred N, Brufsky A, Coleman R, et al.
Cancer Treat Rev
. 2012 Mar;
38(6):798-806.
PMID: 22429722
Current clinical treatment guidelines recommend cytotoxic chemotherapy, endocrine therapy, or both (with targeted therapy if indicated) for premenopausal women with early-stage breast cancer, depending on the biologic characteristics of the...